These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21352832)

  • 21. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
    Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling.
    Buchborn T; Schröder H; Höllt V; Grecksch G
    J Psychopharmacol; 2014 Jun; 28(6):545-52. PubMed ID: 24785760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR; Vanover KE; Pounds L; Johnson RW; Barido R; Anderson GT; Veinbergs I; Dyssegaard A; Brunmark P; Tabatabaei A; Davis RE; Brann MR; Hacksell U; Bonhaus DW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):862-70. PubMed ID: 17519387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat.
    Marona-Lewicka D; Nichols DE
    Neuropharmacology; 1997 Oct; 36(10):1471-5. PubMed ID: 9423936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.
    Meltzer HY; Horiguchi M; Massey BW
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):289-305. PubMed ID: 21212939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
    Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY
    Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia.
    Santini MA; Ratner C; Aznar S; Klein AB; Knudsen GM; Mikkelsen JD
    J Neurosci Res; 2013 May; 91(5):634-41. PubMed ID: 23404493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats.
    Krebs KM; Geyer MA
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):429-37. PubMed ID: 7862855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice.
    Gleason SD; Shannon HE
    Psychopharmacology (Berl); 1997 Jan; 129(1):79-84. PubMed ID: 9122367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI.
    Marona-Lewicka D; Chemel BR; Nichols DE
    Psychopharmacology (Berl); 2009 Apr; 203(2):265-77. PubMed ID: 18604600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of haloperidol-induced patterns of the transcription factor Nur77 and Nor-1 expression by serotonergic and adrenergic drugs in the mouse brain.
    Maheux J; Vuillier L; Mahfouz M; Rouillard C; Lévesque D
    Int J Neuropsychopharmacol; 2012 May; 15(4):509-21. PubMed ID: 21524335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia.
    Martin DA; Marona-Lewicka D; Nichols DE; Nichols CD
    Neuropharmacology; 2014 Aug; 83():1-8. PubMed ID: 24704148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A; Kwek P; Chavez C; van den Buuse M
    J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.
    Siuciak JA; Chapin DS; McCarthy SA; Guanowsky V; Brown J; Chiang P; Marala R; Patterson T; Seymour PA; Swick A; Iredale PA
    Neuropharmacology; 2007 Feb; 52(2):279-90. PubMed ID: 16949622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.
    Marona-Lewicka D; Nichols DE
    Pharmacol Biochem Behav; 2007 Oct; 87(4):453-61. PubMed ID: 17618679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors.
    Zhao C; Li M
    Pharmacol Biochem Behav; 2009 Oct; 93(4):433-42. PubMed ID: 19539643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of prefrontal cortical 5-HT
    Mitazaki S; Nakagawasai O; Onogi H; Watanabe K; Takahashi K; Tan-No K; Quirion R; Srivastava LK; Tadano T
    Behav Brain Res; 2020 Jan; 377():112226. PubMed ID: 31521737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade.
    Fletcher PJ; Rizos Z; Noble K; Higgins GA
    Neuropharmacology; 2011 Sep; 61(3):468-77. PubMed ID: 21402085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
    Burton CL; Rizos Z; Diwan M; Nobrega JN; Fletcher PJ
    Behav Brain Res; 2013 Mar; 240():171-81. PubMed ID: 23201361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine and serotonin interactions in the modulation of the expression of the immediate-early transcription factor, nerve growth factor-inducible B, in the striatum.
    Gervais J; Soghomonian JJ; Richard D; Rouillard C
    Neuroscience; 1999; 91(3):1045-54. PubMed ID: 10391482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.